Pharmaceutical - Financial

Filter

Current filters:

Financial

Popular Filters

1 to 25 of 1092 results

GlaxoSmithKline fined $480 million over China bribery issues

GlaxoSmithKline fined $480 million over China bribery issues

19-09-2014

UK pharma giant GlaxoSmithKline today announced that the Changsha Intermediate People’s Court in Hunan…

ChinaFinancialGlaxoSmithKlineLegalPharmaceutical

Bayer plans to focus entirely on Life Science businesses

Bayer plans to focus entirely on Life Science businesses

18-09-2014

The board of management of Germany’s Bayer AG plans to focus the Bayer Group entirely on the Life Science…

BayerFinancialGermanyManagementPharmaceutical

Merck Serono on track with pharma strategy

Merck Serono on track with pharma strategy

18-09-2014

Germany’s Merck KGaA says that its biopharmaceutical division - Merck Serono - is well on track with…

ataciceptBiosimilarsFinancialGermanyImmunologicalsMerck KGaAMerck SeronoOncologyPharmaceuticalResearchTH-302

Disparity between investment reports as Canada’s Rx&D warns of “serious challenges”

Disparity between investment reports as Canada’s Rx&D warns of “serious challenges”

18-09-2014

Canada’s trade group Research-Based Pharmaceutical Companies (Rx&D) has acknowledged that the environment…

CanadaFinancialPharmaceuticalResearchRx&D

AACR report calls for US cancer funding to be a national priority

AACR report calls for US cancer funding to be a national priority

18-09-2014

Declining budgets have slowed the pace of research into cancer, according to a new report from the American…

AbraxaneCyramzaFinancialGazyvaImbruvicaNexavarOncologyPharmaceuticalResearchTafinlarUSAZydelig

Cardiorentis enters into financing agreement with HealthCare Royalty Partners to fund Ularitide

Cardiorentis enters into financing agreement with HealthCare Royalty Partners to fund Ularitide

17-09-2014

Privately-held Swiss pharma company Cardiorentis AG has entered into a €45 million ($58.3 million)…

Cardio-vascularCardiorentisFinancialPharmaceuticalSwitzerlandUlaritide

Allergan says Pershing’s additional requests for meeting is not “meaningful development”

Allergan says Pershing’s additional requests for meeting is not “meaningful development”

15-09-2014

Hostile takeover target Allergan has said that value is what “really matters” in response to Pershing…

AllerganCanadaFinancialLegalPharmaceuticalUSAValeant Pharmaceuticals International

GSK joins with research councils in UK and South Africa to tackle non-communicable diseases in Africa

GSK joins with research councils in UK and South Africa to tackle non-communicable diseases in Africa

09-09-2014

UK pharma giant GlaxoSmithKline today announced a £5 million ($8.2 million) collaboration with the UK…

FinancialGlaxoSmithKlinePharmaceuticalResearchSouth AfricaUK

Ablynx launches American Depository Receipt program to expand US investor base

Ablynx launches American Depository Receipt program to expand US investor base

05-09-2014

Belgian drug developer Ablynx has launched a Sponsored Level I American Depository Receipt (ADR) program…

AblynxBusiness FinanceFinancialInvestmentPharmaceuticalStock marketUSA

Takeda and Lilly fail to overturn $9 billion award for hiding cancer risk of Actos

Takeda and Lilly fail to overturn $9 billion award for hiding cancer risk of Actos

31-08-2014

Japan’s largest drugmaker Takeda Pharmaceutical and US pharma major Eli Lilly have failed in their…

ActosDiabetesEli LillyFinancialLegalPharmaceuticalTakeda PharmaceuticalUSA

Ipsen posts strong earnings growth for first-half 2014

Ipsen posts strong earnings growth for first-half 2014

29-08-2014

French drugmaker Ipsen has reported first half 2014 sales of 638.7 million euros ($845.1 million), up…

FinancialIpsenPharmaceutical

Edison re-evaluates Onconova based on extended rigosertib timeline after trial failure

Edison re-evaluates Onconova based on extended rigosertib timeline after trial failure

29-08-2014

After failing to meet the primary endpoint of its trial of rigosertib (IV), oncology specialist Onconova…

FinancialMyelodysplastic syndromeOncologyOncology specialistOnconova TherapeuticsPharmaceuticalrigosertibUSA

Recipharm inks deal with Isofol Medical on Modufolin

Recipharm inks deal with Isofol Medical on Modufolin

26-08-2014

Swedish contract development and manufacturing group Recipharm and Isofol Medical AB, a Gothenburg-based…

FinancialIsofol MedicalModufolinOncologyPharmaceuticalProductionRecipharmResearch

US Administration to ensure women’s continued access to contraception coverage, while respecting religious-based objections

US Administration to ensure women’s continued access to contraception coverage, while respecting religious-based objections

25-08-2014

On Friday, the Obama Administration in the USA took several steps to help ensure women, whose coverage…

FinancialPharmaceuticalRegulationReproductiveUSA

Grattan Institute admission shows Australia’s PBS savings proposal was wrong

Grattan Institute admission shows Australia’s PBS savings proposal was wrong

21-08-2014

The Grattan Institute’s proposal on Australia Pharmaceutical Benefits Scheme (PBS) savings has been…

AustraliaFinancialPharmaceuticalPricing

Mood lifts for Medtech in first half of 2014, while Pharma sector faces new struggles

Mood lifts for Medtech in first half of 2014, while Pharma sector faces new struggles

20-08-2014

An M&A frenzy that accounted for nearly $90 billion of equity set the pace for the first half of 2014…

FinancialGlobalJonathan GardnerMergers & AcquisitionsPharmaceutical

Novo Nordisk accepts fine from Danish public prosecutor over financial disclosure

Novo Nordisk accepts fine from Danish public prosecutor over financial disclosure

18-08-2014

Danish insulin giant Novo Nordisk has accepted a fine of 500,000 kroner ($89,735), imposed by the Public…

CopenhagenDanish Financial Supervisory AuthorityDenmarkDiabetesFinancialNovo NordiskPharmaceutical

New Zealand to fund Vidaza and Revlimid

New Zealand to fund Vidaza and Revlimid

13-08-2014

New Zealand’s Pharmaceutical Management Agency PHARMAC says it has approved a proposal for funding…

Celgene Corp.FinancialHealthcareNew ZealandPharmaceuticalPricingRevlimidVidaza

Strong growth forecast for Saudi Arabia pharmaceuticals market

Strong growth forecast for Saudi Arabia pharmaceuticals market

13-08-2014

Pharmaceuticals products sales in Saudi Arabia are expected to exceed a value of $ 7 billion by 2018,…

Business FinanceFinancialMarkets & MarketingPharmaceuticalProductionRest of the WorldSaudi Arabia

ALK Abello reports strong improvement in 2nd-qtr financials

ALK Abello reports strong improvement in 2nd-qtr financials

13-08-2014

Denmark-based allergy specialist ALK Abello has reported significant progress in its sales for the second…

ALK AbelloDenmarkFinanceFinancialNorwegian kronePharmaceuticalRespiratory and Pulmonary

Merck KGaA 2nd-qtr earnings beat expectations

Merck KGaA 2nd-qtr earnings beat expectations

13-08-2014

German pharmaceuticals and chemicals major Merck KGaA said this morning that it has generated organic…

Business FinanceFinancialGermanyMerck KGaAMerck SeronoPharmaceutical

Boehringer Ingelheim sees 1st-half sales fall, but overcomes challenges

Boehringer Ingelheim sees 1st-half sales fall, but overcomes challenges

12-08-2014

German family-owned pharma major Boehringer Ingelheim reported first-half 2014 results, showing that…

Boehringer IngelheimChronic obstructive pulmonary disease therapyFinancialGermanyPharmaceutical

US federal drug discount program “faces challenges as it expands”

US federal drug discount program “faces challenges as it expands”

12-08-2014

A federal program that provides billions in drug discounts to safety net hospitals and other health care…

FinancialHealthHealth Medical PharmaHealthcarePharmaceuticalPharmaceutical industryPharmacologyRANDRegulationUSA

Prosensa and CureDuchenne expand DMD collaboration with $7 million funding boost

Prosensa and CureDuchenne expand DMD collaboration with $7 million funding boost

12-08-2014

Dutch biotech company Prosensa will receive a 5 million euros ($7 million) funding boost from US non-profit…

Duchenne Muscular DystrophyFinancialNetherlandsPharmaceuticalProsensaRare diseasesResearchUSA

1 to 25 of 1092 results

Back to top